On the most recent anniversary of my eviction from the womb, I turned the key to my dorm and swung open the door to discover ...

1, the parent strain of the most common currently circulating variants. The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

Struggling biotech Novavax (NASDAQ: NVAX) was a hot buy a few years ago as it was in the midst of developing a vaccine for COVID-19. Ultimately, it did produce an approved vaccine, but it was a ...

The Philadelphia Eagles said posters popping up in Philadelphia that show the team has endorsed Vice President Harris are “counterfeit political ads.” The posters appeared at bus stop shelters ...

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and said the vaccine is ready to ship. Novavax received the green light from ...

PHILADELPHIA (CBS) -- A poster that's popping up around the city of Philadelphia alleges the Eagles have officially endorsed Vice President Kamala Harris which has left the Birds to debunk the rumors.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, we discuss the woman who spearheaded progress in ...

The emergency use authorisation from the FDA allows for Novavax’s updated Covid-19 vaccine to be used in individuals 12 years and older. Credit: Aha-Soft / Shutterstock. Novavax has joined its peers ...

SILVER SPRING, Md., Aug. 30, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that ...

Novavax has secured a transformative partnership with Sanofi, which includes $1.2 billion in potential payments and critical commercial support. The company’s COVID-19 vaccine targets the JN.1 ...

Aug. 31 (UPI) --A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that are now circulating. The U.S. Food and Drug ...